(Q33886753)

29 July 2017

1 reference

title

Hormonal pathology of the endometrium (English)

1 reference

29 July 2017

Deligdisch L

1

1 reference

29 July 2017

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

13

1 reference

29 July 2017

3

1 reference

29 July 2017

285-294

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3880050

29 July 2017

0 references

cites work

Ultrastructural features in normal and hyperplastic postmenopausal endometrium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

Hormonal manipulation of endometrial maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

Development of endometrial cancer in women on estrogen and progestin hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

A retrospective study of tamoxifen and endometrial cancer in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

Endometrial cancer in elderly women: A histologic and steroid receptor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

Combined Estrogen and Progesterone Use and Endometrial Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

Effects of oral and intrauterine administration of contraceptives on the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

The effects of clomiphene citrate on the histology of human endometrium in regularly cycling women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin/human chorionic gonadotropin for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Influence of superovulation on endometrial and embryonic development

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Precursors of corpus carcinoma estrogens and adenomatous hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Continuous estrogen/progestin therapy in menopause

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

A randomized trial of adjuvant progestagen in early endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Progesterone receptors in two groups of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

Endometrial carcinoma in elderly women

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880050

7 January 2021

10.1038/MODPATHOL.3880050

Identifiers

DOI

1 reference

PubMed ID

10757339

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10757339